McKesson doesn't expect Rite Aid's bankruptcy to have much affect on profit outlook, liquidity
McKesson Corp. (MCK) disclosed Monday that it doesn't expect drugstore chain Rite Aid Corp.'s (RAD) bankruptcy announced over the weekend to have a material impact on its adjusted earnings outlook for fiscal 2024. The health care supply and retail pharmacy company added that Rite Aid's bankruptcy isn't expected to have a material impact on its liquidity position or operations. McKesson's stock was still inactive in premarket trading, while Rite Aid shares were halted. On Aug. 2, McKesson said it expects fiscal 2024 adjusted EPS of $26.55 to $27.35,which compares with the current FactSet consensus of $27.19. The company is slated to release fiscal second-quarter results on Nov. 1. McKesson's stock has rallied 13% over the past three months through Friday while the S&P 500 has slipped 3.9%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-16-23 0729ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing